FI790740A - Foerfarande foer framstaellning av nya karbamid- och amidofoereningar - Google Patents

Foerfarande foer framstaellning av nya karbamid- och amidofoereningar

Info

Publication number
FI790740A
FI790740A FI790740A FI790740A FI790740A FI 790740 A FI790740 A FI 790740A FI 790740 A FI790740 A FI 790740A FI 790740 A FI790740 A FI 790740A FI 790740 A FI790740 A FI 790740A
Authority
FI
Finland
Prior art keywords
care
amounting
freezing
care care
Prior art date
Application number
FI790740A
Other languages
English (en)
Other versions
FI70708C (fi
FI70708B (fi
Inventor
Adrian Marxer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI790740A publication Critical patent/FI790740A/fi
Application granted granted Critical
Publication of FI70708B publication Critical patent/FI70708B/fi
Publication of FI70708C publication Critical patent/FI70708C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI790740A 1978-03-08 1979-03-05 Foerfarande foer framstaellning av nya farmaceutiskt anvaendbara 2-imidazolin-1-yl-urinaemne- och -amidofoereningar FI70708C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH251978 1978-03-08
CH251978 1978-03-08

Publications (3)

Publication Number Publication Date
FI790740A true FI790740A (fi) 1979-09-09
FI70708B FI70708B (fi) 1986-06-26
FI70708C FI70708C (fi) 1986-10-06

Family

ID=4235609

Family Applications (1)

Application Number Title Priority Date Filing Date
FI790740A FI70708C (fi) 1978-03-08 1979-03-05 Foerfarande foer framstaellning av nya farmaceutiskt anvaendbara 2-imidazolin-1-yl-urinaemne- och -amidofoereningar

Country Status (28)

Country Link
US (2) US4292429A (fi)
EP (1) EP0004561B1 (fi)
JP (1) JPS54125668A (fi)
KR (2) KR820002098B1 (fi)
AR (2) AR225010A1 (fi)
AT (1) AT364375B (fi)
AU (1) AU531006B2 (fi)
CS (1) CS244656B2 (fi)
CY (1) CY1304A (fi)
DD (1) DD142336A5 (fi)
DE (1) DE2961198D1 (fi)
DK (1) DK95279A (fi)
ES (1) ES478342A1 (fi)
FI (1) FI70708C (fi)
GB (1) GB2016011B (fi)
GR (1) GR71998B (fi)
HK (1) HK80185A (fi)
HU (1) HU182940B (fi)
IL (1) IL56797A (fi)
MY (1) MY8700199A (fi)
NO (1) NO152606C (fi)
NZ (1) NZ189841A (fi)
OA (1) OA06201A (fi)
PH (1) PH16207A (fi)
PL (2) PL123150B1 (fi)
PT (1) PT69314A (fi)
SU (2) SU845779A3 (fi)
ZA (1) ZA791062B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338453A (en) 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
US4353921A (en) * 1981-06-19 1982-10-12 Berlex Laboratories, Inc. Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use
DE3213509A1 (de) * 1982-04-10 1983-10-20 Basf Ag, 6700 Ludwigshafen N-substituierte imidazol-derivate, ihre herstellung, diese enthaltende arzneimittel und ihre verwendung
JPS6133173A (ja) * 1984-07-25 1986-02-17 Torii Yakuhin Kk アミジン化合物
AU5234886A (en) * 1984-12-12 1986-07-01 MTD-Produkter I Smaland A.B. Method of preparing a hospital room or the like
GB8906198D0 (en) * 1989-03-17 1989-05-04 Ciba Geigy Ag Compounds
NZ563054A (en) * 2005-05-03 2010-09-30 Pharma Mar Sa Antitumoral tetrahydro-pyrimidines
FR2901273B1 (fr) 2006-05-19 2010-12-24 Anaconda Pharma Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant
NZ592264A (en) 2008-09-17 2013-10-25 William Kingston Tideway anchor system
BR112012021657B8 (pt) 2010-03-04 2022-06-07 Ea Pharma Co Ltd Composto, agente farmacêutico, agente para conferir kokumi , e, tempero
WO2011108724A1 (ja) * 2010-03-04 2011-09-09 味の素株式会社 糖尿病又は肥満症の予防又は治療剤
CN102924380B (zh) * 2012-11-13 2014-12-31 齐鲁动物保健品有限公司 一种咪唑苯脲的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH234990A (de) * 1938-05-11 1944-10-31 Chem Ind Basel Verfahren zur Darstellung eines neuen therapeutisch wirksamen Amidins.
GB813525A (en) * 1956-07-09 1959-05-21 Socony Mobil Oil Co Inc Fuel oil composition
GB1082964A (en) * 1963-06-25 1967-09-13 Wellcome Found New substituted imidazolines and their preparation and use
US3455940A (en) * 1965-12-07 1969-07-15 Herbert C Stecker Certain halo and dihalo n-substituted salicylamides
GB1174349A (en) * 1966-08-25 1969-12-17 Boehringer Sohn Ingelheim Novel 2-Anilinomethylimidazoline Derivatives and process for the preparation thereof
US3846071A (en) * 1969-02-12 1974-11-05 Petrolite Corp Process of inhibiting corrosion by treatment with phosphate-cyclic amidine salts
NL7415845A (nl) * 1973-12-26 1975-06-30 Upjohn Co Werkwijze voor het bevorderen van de productie van endogene prostaglandinen door zoogdieren, alsmede werkwijze ter bereiding van daarbij te gebruiken preparaten.
US4088766A (en) * 1975-06-25 1978-05-09 The Upjohn Company Urea containing compositions and methods
US4233451A (en) * 1976-05-20 1980-11-11 The Procter & Gamble Company Process for making imidazolinium salts
US4353921A (en) * 1981-06-19 1982-10-12 Berlex Laboratories, Inc. Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use

Also Published As

Publication number Publication date
PL123150B1 (en) 1982-09-30
EP0004561A3 (en) 1979-11-14
ZA791062B (en) 1980-03-26
ATA171079A (de) 1981-03-15
NO152606B (no) 1985-07-15
AR225010A1 (es) 1982-02-15
AU4490079A (en) 1979-09-13
KR820002098B1 (ko) 1982-11-05
PH16207A (en) 1983-08-05
CS244656B2 (en) 1986-08-14
OA06201A (fr) 1981-06-30
DK95279A (da) 1979-09-09
AU531006B2 (en) 1983-08-04
JPS54125668A (en) 1979-09-29
FI70708C (fi) 1986-10-06
DD142336A5 (de) 1980-06-18
NO152606C (no) 1985-10-23
KR830000884B1 (ko) 1983-04-26
PL213924A1 (fi) 1980-02-25
EP0004561B1 (de) 1981-11-04
DE2961198D1 (en) 1982-01-14
US4292429A (en) 1981-09-29
PL116762B1 (en) 1981-06-30
GB2016011A (en) 1979-09-19
AR227286A1 (es) 1982-10-15
SU845779A3 (ru) 1981-07-07
HK80185A (en) 1985-10-25
NO790765L (no) 1979-09-11
HU182940B (en) 1984-03-28
SU923367A3 (ru) 1982-04-23
US4420619A (en) 1983-12-13
CY1304A (en) 1985-12-06
GR71998B (fi) 1983-08-26
MY8700199A (en) 1987-12-31
PT69314A (de) 1979-04-01
JPS629109B2 (fi) 1987-02-26
ES478342A1 (es) 1979-05-16
GB2016011B (en) 1982-08-25
IL56797A (en) 1982-09-30
AT364375B (de) 1981-10-12
NZ189841A (en) 1982-03-09
EP0004561A2 (de) 1979-10-17
FI70708B (fi) 1986-06-26

Similar Documents

Publication Publication Date Title
FI801609A (fi) Foerfarande foer framstaellning av nya kefalosporinantibiotika
FI792082A (fi) Framstaellning av nya fenetanolaminer
FI791084A (fi) Nya n-heterocyklo-4-piperidinaminer
FI791754A (fi) Nya aminotiazoler
FI790640A (fi) Nya resorberbara galeniska kompositioner
FI792567A (fi) Nya spiro-oxazolidinoner
FI791679A (fi) Foerfarande foer framstaellning av nya kefalosporinantibiotika
FI792080A (fi) Framstaellning av nya fenetanolaminer
FI792079A (fi) Processer foer framstaellning av nya fenetanolaminer
FI55353C (fi) Foerfarande foer framstaellning av nya antracyklinantibiotika
FI790740A (fi) Foerfarande foer framstaellning av nya karbamid- och amidofoereningar
FI801618A (fi) Foerfarande foer framstaellning av nya penicillansyraderivat
FI800298A (fi) Foerfarande foer framstaellning av nya antracyklina derivater
FI772565A (fi) Foerfarande foer framstaellning av nya bensopyranderivat
SE7909023L (sv) Nya azolylketaler
FI790820A (fi) Foerfarande foer framstaellning av nya n-fenylalaninderivat
FI792076A (fi) Foerfarande foer framstaellning av nya fenylpiperidinderivat
FI791210A (fi) Nya benzodioxolderivat
FI790285A (fi) Foerfarande foer framstaellning av nya purinderivat
FI791183A (fi) Foerfarande foer framstaellning av nya oximer haerledda fraon 3-azidometyl-7-amino-tiazolyl-acetamidocefalosporansyra
FI773846A (fi) Foerfarande foer framstaellning av nya sulfamoylbentsoesyror
FI792078A (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara propylaminderivat
FI773743A (fi) Foerfarande foer framstaellning av nya piperazinderivat
FI793215A (fi) Nya tricykliska ortofusionerade kvaeve innehaollande foereningar
FI791439A (fi) Nya foereningar av n-cyano-azometiner

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: CIBA-GEIGY AG